Phase 3 - Ongoing, Not Recruiting
Enrollment: 382
Drug: Intravenous Infusion
Type: Interventional
Open Label: Yes
Countries: Australia, Belgium, CA, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom, US